thumbnail image
  • Home
  • Longevity School
  • Rejuvenation Leaderboard
  • Level 1 Questionnaires
  • Journal
  • Software
  • About 
    • Oliver Zolman
    • Our mission
    • Scientific Advisory Board
  • Resources 
    • PhenoAge Calculator
    • Sleep
    • Longevity Level 1, 2, 3 Guides
    • Blog
    • YouTube
  • Contact 
    • Contact Us
    • LinkedIn
    • Donate
    • Twitter
    • Facebook
    • Instagram
  • …  
    • Home
    • Longevity School
    • Rejuvenation Leaderboard
    • Level 1 Questionnaires
    • Journal
    • Software
    • About 
      • Oliver Zolman
      • Our mission
      • Scientific Advisory Board
    • Resources 
      • PhenoAge Calculator
      • Sleep
      • Longevity Level 1, 2, 3 Guides
      • Blog
      • YouTube
    • Contact 
      • Contact Us
      • LinkedIn
      • Donate
      • Twitter
      • Facebook
      • Instagram
  • Home
  • Longevity School
  • Rejuvenation Leaderboard
  • Level 1 Questionnaires
  • Journal
  • Software
  • About 
    • Oliver Zolman
    • Our mission
    • Scientific Advisory Board
  • Resources 
    • PhenoAge Calculator
    • Sleep
    • Longevity Level 1, 2, 3 Guides
    • Blog
    • YouTube
  • Contact 
    • Contact Us
    • LinkedIn
    • Donate
    • Twitter
    • Facebook
    • Instagram
  • …  
    • Home
    • Longevity School
    • Rejuvenation Leaderboard
    • Level 1 Questionnaires
    • Journal
    • Software
    • About 
      • Oliver Zolman
      • Our mission
      • Scientific Advisory Board
    • Resources 
      • PhenoAge Calculator
      • Sleep
      • Longevity Level 1, 2, 3 Guides
      • Blog
      • YouTube
    • Contact 
      • Contact Us
      • LinkedIn
      • Donate
      • Twitter
      • Facebook
      • Instagram
  • The only total body skin rejuvenation service

    • Rejuvenates up to 100% of your skin, not just your face
    • Evidence-based protocol by Dr Oliver Zolman MBBS BSc
    • For men & women, able to visit Cambridge
    • 4+ sessions per year for maximum effect
    • Up to 10x cheaper than standard UK & USA clinics*

    Start my membership
  • Did you know that all skin ages, regardless of sun exposure?

    Why not just treat the face?

    How are you 10x cheaper?

    How does the skin age?

  • Is this the only protocol that realistically can keep skin looking decades younger for your next 30 years?

     Dr Patrick Bitter MD, FAAD, 2020, BBL Pioneer

    "With BBL HERO we can now make a real promise to our patients that we can keep their skin looking decades younger for the next thirty years of their life with regular treatments"

     

    "No treatment I have ever done before has come closer to making skin look like young people's skin than BBL HERO"

     

  • What do patients say?

     'People stop me on the street and one lady even asked to touch my face'

    1 week after first treatment

    'Where's your pores, why is your skin so smooth, why does your skin look tighter?'

    1 day after first treatment

    I was interrupted mid conversation and she said "your skin is literally unbelievable! It glows"

    3 months after first treatment

  • The Half Day in-clinic experience

     Our whole body skin rejuvenation therapies are delivered in 3+ hour sessions at a time and represent the best first line therapies for the average person, regardless of age, for causing true rejuvenation of their entire skin surface area. This is in opposition to fake rejuvenation like botox or fillers.

     

    • Indicated population: Age 18+, male or female, skin types 1 - 5 (not skin type 6) 
    • No anaesthetic required 
    • No/low pain
    • No downtime
    • Research grade whole body skin bioloigcal age measurements to prove rejuvenation and enable personalisation of therapy 

    Unique whole body BBL 360 Protocol built by Dr Zolman

     

    Total body LED light

     

    Diathermy to remove benign moles & raised lesions

     

    Referral to whole body mole check with dermatoscopy, dermatologist & optional biopsy

     

    Motorised micro-needling for extra wrinkle reduction

     

    Total body skin biological age measurements

     

    Massage by a masseuse

     

    Free snacks

     

    Immersive audio experience, or choose your playlist

     

  • The after care experience

     These interventions further enhance skin rejuvenation from the inside-out. Evidence based routines and programs & referrrals are designed for you, with recommended no-affiliate conflict of interest free  purchases to make. Costs associated with these e.g. topical skin care, supplements, gym membership, are not included with your membership. 

    Home Skincare routine

     

    Diet, Exercise & Joints program

     

    Supplements program

     

    Referrals

     Dermatologists &  advanced rejuvenation services

  • What We Don't Do

    *Note that all these therapies have use for some individuals in specific situations but generally, for truly rejuvenating the average person's whole skin surface area, regardless of age, the below therapies are not first line interventions for 'true rejuvenation' of skin & subcutaenous fat 

    Dermarolling, plasma pen. 

    May cause scar-collagen & inflammatory-accelerated aging.

    RF micro-needling, HIFU or Coolsculpting

    Over 1% chance of permanent disfigurement.

    Surgery

    Risk of scarring, unnatural looks, sagging, and intensive anaesthesia risks.

    Botox or HA fillers

    Potentially 'pseudo-rejuvenative' therapies, with risk of nerve, vessel and fibrosis damage.

    LASERS

    • Causes microfibrosis pseudorejuvenation rather than true rejuvenation
    • Requires anaesthetic making it inconvenient to do the whole body as requires multiple sessions
    • Topical anaesthetics such as lidocaine are likely adipose stem cell cytotoxins, these cell types make up a large proportion of the epidermal and dermal cell counts

    Things we are considering

    • Renuva autopsy derived fat ECM for true rejuvenative volume restoration
    • Gentle RF-microneedle for scars, laxity and senolysis
    • Gentle micro-needling for IGF-1 boosting and non-scar collagen induction 
    • Nanolaser peels or gentle lasers for senescent fibroblast removal
    • Profhilo for volume loss (less pseudorejuvenative than fillers)
    • Sculptra PLLA for volume loss on the body (less pseudorejuvenative than fillers) 
    • Electro-poration to enhance specific compound transdermal delivery
    • PRP/PRF for volume loss, scars (in combo with microneedle/RFM), or genetic low volume e.g. dark circles 
    • HIFU, EMS, RF for genetic fat reduction
  • Our unique whole body protocol

    "Slow Skin Rejuvenation”: 'the gradual restoration of characteristics of youthfulness to skin cells and tissues over 12+ months'

    Track your rejuvenation

    with skin age biomarkers

    To prove your skin is getting younger we measure your skin's biological age across 16 body regions after each visit

    • Biological age of your skin across 16 different regions using Zolman-Merz scores
    • 120+ megapixel research grade 'before and after' photos of your face and your other oldest skin areas
    • Skin dermal glycation imaging (increases with age)
    • Sub-surface imaging of deep melanin, superficial melanin & haemoglobin pigments
    • AI surface imaging of skin texture, deep & shallow wrinkles
    • AI imaging of mean eyelashes length & volume (eyelash biological age)
    • Digital polarised dermatoscopy of skin conditions with referral to a dermatologist 
    • Optional scarless skin biopsy 

    Phase 1 - 'Slow Skin Rejuvenation' protocol

    Personalised in-clinic and at-home skin rejuvenation protocol over 12 months.

     

    This typically includes 6 multi-hour visits across 12 months.

    Phase 2 - Maintenance protocol

    After achieving the desired rejuvenation, we perform a maintenance protocol aimed to maintain your skin at your new biologically younger age indefinitely.

  • Learn more about the BroadBand Light component

    Oliver Zolman is the inventor of BBL 360 and SkinTyte 360, the only multi-hour procedure repeated several times to induce skin rejuvenation across the entire skin surface area.

    See an example of how a whole body BBL therapy is performed

    Note: this video shows an abbreviated whole body protocol

    BBL HERO Testimonials

    See what others are saying about BBL HERO.

    BBL SkinTyte Testimonials

  • Start Your Membership

    From £995 per year

  • Gallery

  • The Evidence

    See a summary of studies on different skin therapies

    More data added each week

    Evidence Review: 

    Intense Pulsed Light

    Peer-reviewed studies

     

    Rejuvenation of biological aging of the skin

    • Completely prevented facial aging, if done at least annually, when used with retinoids, vitamin C and sunscreen, for 10 years (N=10, Stanford Study), making people look 12 years younger than their chronological age
    • Reversed skin epidermal & dermal gene expression around 50% towards age 25 levels from age 55 levels (e.g. age 55 to age 40) after just 3 treatments spaced 1 month apart (N=10, Stanford Study)
    • Rejuvenated 1,300 genes to young levels after 3 therapies (N=10, Stanford Study)
    • "After almost 2 decades of using BBL, our experience has shown that patients appear younger than their actual age following long-term treatment and routine maintenance with BBL"
    • Reduced arm wrinkles 70%, abnormal pigmentation 55%, and global assessment score 50%,  (N=10 Stanford study)
    • Reduced elastosis in aged skin on H&E stain and Von Giesen stain (Stanford Study)
    • Increased uniformity of aged collagen fibres on PAS stain (Stanford study)
    • Enhanced fractional CO2 LASER wrinkle reduction (3 sessions, 2 months apart) by removing more wrinkles, reducing healing time from 14 days to 7 days, and post treatment redness from 8 days to 4 days, than LASER alone (RCT)
    • In women in their 60s-70s, 3 sessions of IPL spaced 6 weeks apart, back of hand skin wrinkle size was reduced 25% and roughness 15%, doubled thickness of collagen band below the epidermis (RCT)
    Actinic keratoses
    • Provided 50% resolution of AKs after 3 treatments spaced 6 weeks apart when IPL was combined with methyl aminolaevulinate (MAL)  (RCT)
    General redness of the skin
    • 2 sessions spaced 1 month apart reduced diffuse facial redness by 60%, outperforming pulsed dye LASER (RCT)
    • 2 sessions of BBL IPL spaced 1 month apart reduced severe facial erythema by 35%, outperforming the previous gold standard of nonpurpuric (non bruising non blood vessel bursting) Pulsed Dye LASER, which only showed 25% reduction, it was theorised IPL may produce continued reductions if waiting longer than 2 months, BBL IPL also provided the benefit of providing larger skin area coverage due to larger spot size (RCT)
    Scars
    • Improved Patient Observer Scar Assessment Scale (POSAS) to reduce post-operative abdominal scars 10x better than ErbYag LASER alone, 1 week after surgery, and 2 sessions spaced monthly after this (RCT)
    • Improved erythematous hypertrophic scars twice as fast when IPL was done before fractional ablative CO2 LASER, over 4 sessions (RCT)
    Acne
    • IPL sessions 2 x per week for 4 weeks, 8 sessions total, with isotretinoin versus isotretinoin alone reduced acne lesions by 50% rather than 25% with isotretinoin alone, as well as reduced relapse rates by 50%, allowed a lower dose of isotretinoin to be used, increased chance of erythema resolution by 3x and gave a chance of lightening the skin by 5x (RCT)
    • Note that IPL did not work for acne when it was spaced once every 2 weeks for 3 sessions, rather than 4 times every 2 weeks as above, but NdYAG LASER did (RCT)
    • 50% reduction in acne in 1 month, rather than 25% for bi-weekly IPL sessions alone, by combining blue IPL with twice daily licochalcone A, l‐carnitine, and 1,2‐decanediol cream (RCT)
    • IPL done once monthly for 3 months, total 3 sessions, when combined with 5% benzoyl peroxide once nightly overnight and washed off in the morning, outperformed benzoyl peroxide alone, showing double the reduction in Acne Global Severity Score by 4 months, 75% reduction in total acne lesions rather than 50% and 2.5x higher patient satisfaction score than benzoyl peroxide alone, all at 4 months (RCT)
    • Once weekly IPL with meythlene blue liposomes (to enhance penetration into the skin) for 3 sessions, showed 45% reduction in backne (back acne) at ONE MONTH, versus 25% for IPL 550 nm alone. Methods used: On the one side of the back, topical liposomal methylene blue hydrogel was applied under occlusion by a silver reflective plastic wrap for 60 min. The remaining gel was removed before being illuminated by the IPL on the one side of the back, topical liposomal methylene blue hydrogel was applied under occlusion by a silver reflective plastic wrap for 60 min. The remaining gel was removed before being illuminated by the IPL at 550 nm,  with methylene blue peak absorption at 610-650 nm. Methylene Blue is a cheaper option to MAL and ALA phytodynamic therapy topicals (RCT)
    Hair reduction
    • 6 x monthly IPL treatments reduced unwanted facial hair by 60%, this was extended to a 90% reduction when combined with topical eflornithine twice daily (RCT)
    • IPL versus LASER:  over 7 treatments spaced 4-6 weeks apart over 7 months, Super Hair Removal Alma IPL at 3Hz, 7J/cm^2, and 10-13 kJ energy per 4x4 cm area (15 cm^2) outperformed LASER ErbYAG hair reduction, removing 80% of hair rather than 70% (both maintained for 18 months after treatment), and with 66% less redness, 90% less swelling, 66% less burning crusting sensation and 85% less overall pain (RCT)
    • IPL was less painful than ErbYAG for skin types 5-6 hair removal (RCT)
    Rosacea
    • Reduced chance of telangiectasia recurrence in rosacea 5x versus anti-mite treatment monotherapy (RCT)
    • Effectively reduced rosacea over 4 sessions spaced 3 weeks apart with no adverse effects (RCT)
    Melasma
    • Triple combination cream therapy and IPL combined reduced melasma better than either therapy alone (RCT)
    • Topical transexamic acid combined with IPL outperformed IPL alone (RCT)
    Keratosis pilaris
    • Effective (RCT)
    Fungal nail infection
    • Nail plates were softened with urea 40% by occlusive dressing for 12 hours during 3-7 days before treatments. Then, eight sessions separated by an interval of 2 weeks, of IPL were done, there was 80% complete cure by 3 months after the last treatment, slightly higher than photodynamic therapy (RCT)
    Dry eye disease, Meibomian gland dysfunction
    • 3 sessions of M22 brand IPL with dry eye mode outperformed tea tree oil 5% alone (RCT)
    Methods to reduce redness and pain after IPL treatment, without reducing treatment efficacy
    • An alpha 2 agonist, topical brimonidine, normally used for glaucoma was applied after each of 3 IPL treatments done for severe telangiectasia (spider veins), causing 75% reduction in redness post treatment, versus only 25% reduction from air cooling alone control group and reduced post IPL pain from 2/10 to 1/10 (RCT)
    • Keeping energy levels to under 22 J/cm^2 in type 1-3 skin types, or under 15 J/cm^2 in type 4+ skin types should keep pain score to 1/10 (RCT)

    Advanced IPL evidence: 

    4Hz BBL 

    4 Hz BBL allows for 4x more pulses per treatment session, first commercially available in 2020, 4 Hz BBL is showing early data that is creating results not possible with 1 Hz BBL before (Dermatological Reviews, Jan 2021)

    • Allows treatment of the whole body due to time saving
    • Easier for operators to perform without years of experience, allowing more predictable consistent results
    • Greater patient satisfaction
    • Faster results
    • Greater improvement in fine lines and laxity
    • More comfortable treatment

    Expert opinion on 4 Hz BBL for Skin Cancer & Aging Prevention

    Patrick Bitter MD, FAAD, with 25 years experience in Light Therapies in Dermatology (Dermatological Reviews, Jan 2021), weighs in on the benefits of 4 Hz BBL in this 2021 Review

     

    'We may see a decrease in the development of skin lesions associated with aging, such as seborrheic keratoses, lentigines, AKs, and possibly nonmelanoma skin cancer with regular IPL treatments.'

     

    'Because BBL HERO (4Hz BBL) results leave skin even younger-appearing than the results with traditional BBL, I would speculate that there may be an even greater degree of gene revitalization with BBL HERO than BBL. '

     

    'It is now apparent that doing 8–10 passes over the cheek produces a degree of textural improvement of pores and fine lines beyond what has ever been seen or expected with other IPL technologies. Eight passes can be done at the same time as two passes when pulsing at the maximal pulse rate of 4 Hz (four pulses per second). Early treatments with BBL HERO on the face results have shown higher patient satisfaction because of faster results, greater improvement in fine lines and skin laxity, and more comfortable treatments compared with traditional IPL treatments.'

     

    'The optimal treatment schedule to delay skin aging with IPL is not yet clearly known. What is known is that there is no upper limit to the number of treatments with IPL that someone can have and that the more IPL treatments one receives, the better appearing skin becomes. Current regimens to delay skin aging with IPL vary from two to six treatments per year. Some individuals choose to receive monthly IPL treatments. Receiving numerous IPL treatments over an extended period of time appears safe with no reported adverse effects as long as proper parameters and treatment protocols are used. There has been no adverse long‐term sequelae in individuals who have received even more than 100 treatments over a 20‐year period of time. Indeed, it appears that those people receiving numerous treatments are able to maintain clear and smooth skin over a period of years'

    Evidence-review Microneedling

    PubMed RCT high accuracy literature search results:

     

    Wrinkles

    • Rejuvapen; Refine USA, Jacksonville, Florida, at a setting of 0.5mm for all treated areas with ONE PASS for 4 sessions spaced 1 month apart, using a hyaluronic acid gel, every four weeks on 10 patients (women age 35-60). Reduced VISIA skin texture score 30%, improved skin hydration 33%, fine lines and wrinkles 33%, eveness of skin tone 33%, age spots 33% (RCT) 
    • A dissolving microneedle patch of 650 cone shaped microneedles left on for 25 minutes with 75% of the needles dissolving in this time, with microneedles 0.35 mm wide at the base and 0.45 mm deep, done twice per week with topical 40kDa HA, 4.5 mg total HA, and 0.3 micrograms total ferulic acid for 3 weeks reduced under eye wrinkles by 66% (RCT)
    • Improved wrinkles 33%, facial laxity a significant but unspecified amount and dyschromia 30%, with only 15% experiencing pain, rather than 50%, and only 2 days rather than 4 days downtime compared to ERBYAG LASER:  three sessions of microneedling 1 month apart (Dermapen; 3MED Group). The cartridges were single-use containing 12 sterile needles. The following needle depths were used to achieve pinpoint bleeding: 1.5-2.5 millimeters (mm) for different facial parts and 0.5-1 mm for the periorbital area. The frequency of the needle stroke was from 100 to 150 Hz. The needle cartridge was then moved in a circular pattern across the face. At the end of both treatments, the skin was cleansed with warm water, and zinc oxide ointment was advised to cover the treatment area and the patients were explained about sun protection. (RCT)
    • Dermaroller: Each volunteer had received one session every 2 weeks for six sessions. The face was sterilized with povidone iodine and alcohol. The area to be treated had been anesthetized with topical combined anesthesia formed of 2.5% prilocaine + 2.5% lidocaine (EMLA cream; Astra Zeneca UK Limited, Macclesfield, Cheshire, UK) for 45–60 minutes. The treatment had been done using the needling tool (dermaroller, ADROLL TD, Spain), which has 600 stainless steel, mechanically strong and nontoxic needles arranged in 10 rows with a needle length of 1 mm. The dermaroller had been passed over the affected areas eight times in four directions (vertical, horizontal, and two diagonal). Pinpoint bleeding and oozing at the needle puncture areas on the skin lasted from 30 seconds to 2 minutes followed by saline soaked gauze swabs used to soak up any fluid ooze and minimize the pain. (RCT)
    • Electroporting or 0.5mm dermarolling in vitamin c 20% at pH 3.5 may enhance elasticity after 4 sessions 10 days apart (RCT)
    • Adding HA serum after microneedling may enhance general outcomes (RCT)
    • 0.5 mm dermaroller every 2 weeks for 10 weeks when combined with human adipose derived fat stem cell exosomal extract from Korea caused crow's feet reduction by 30% (RCT)
    • Pinpoint bleeding may not be needed for clinical effect (Derm expert opinions)

     

    Reducing microneedle pain other than anaesthetic

    • Doubling the microneedle length quadruples the pain, reducing the number of microneedles reduced the pain (RCT)

     

    Enhancing microneedle outcomes

    • Adding diclofenac 3% gel to 0.8 mm microneedles may enhance long term penetration of gel patch applied over the microneedle site. The array was pressed gently into the skin for 15 – 20 seconds and immediately removed, creating a grid of 50 micropores. A 2nd insertion was applied, rotating the array 45° to c reate a total of 100 non-overlapping micropores.  All treatment sites, regardless of assigned group, were wiped with 70% isopropyl alcohol pads and allowed to dry. Subjects assigned to MN groups were treated with MN arrays at each site before gel patch application. Group 1 received 2×8 MN array insertions per subject, creating 800 total micropores for eight patch sites; Group 2 received 2×2 MN array insertions, creating 200 total micropores. In Group 1, each MN site was treated with 3% diclofenac gel (100 μl, rubbed gently into the skin), followed by NTX gel (500 μl) and occlusion with a blank patch. (RCT)

     

    • Acne scars
    • Microneedling + TCA chemical peel created the best results in acne scar reduction (Goodman Baron scale (ref) from 2.9 to 2.0 after 4 sessions spaced 3 weeks apart) . Microneedling was performed with the use of an automatic dermapen (Dermapen, Revisage, Poland) on the facial skin area planned for treatment. Needle penetration depth was set to 2 mm. Microneedling lasted 20 min. (RCT)
    • Autologous plasma effect on acne scars was enhanced when dermaroller was combined (RCT)
    • Monotherapy dermaroller alone effective for scar reduction with 75% satisfaction rate. The skin of the face was stretched by one hand while the other is used to roll the instrument over in a direction perpendicular to that of stretching force. The roller was rolled 15 to 20 times in horizontal, vertical and both oblique directions till pin point bleeding occur, which should be from the base of the scar. Saline pads are kept over the treated area. Topical antibiotic cream was applied over treated areas. The whole procedure takes 15 to 20 minutes (RCT)
    • Expert opinion:  Following microneedling hypotrophic scars “raise” to skin level and former hypertrophic scars “fall” to skin level. While the new tissue of previously hypotrophic scars requires about 3-5 months after 1–3 microneedling treatments with Dermaroller®, this process takes several months (longer) in hypertrophic scars and burn scars. These scars do not respond to microneedling as well as hypotrophic scars. The failure rate may be around 30%. (ref)

    Melasma

    • Our study shows equal efficacy of microneedling and QS Nd:YAG laser when combined with topical 3% TA gel in treating melasma without serious side effects. Microneedling has more downtime and maybe less preferable as a lunchtime procedure. (RCT)

    Plantar warts

    • 6 sessions 2 weeks apart with topical anaesthetic; The wart was cleaned with alcohol and then a scalpel was used to remove the associated callus. Topical anesthetic cream was applied for 60 min before the procedures. Microneedling was performed on each wart using dermapen (Dermapen 3, Avon UK) supplied with 12 needles arranged in rows. The penetration depth was adjusted at 2-mm, endpoint was pinpoint bleeding and the dermapen was held by the hand in a vertical direction on the warts, 5-FU can be added topically to increase total chance of clearance from 70% to 85% (RCT) 

    Infra-orbital dark circles

    • Phenylethyl resorcinol (PR), also known as SymWhite®377, is a potent inhibitor of tyrosinase. It has been reported to be one of the strongest skin-lightening agents and 22-fold more effective than kojic acid.5 The nano-microneedle is a new device that can promote the transdermal absorption of topical agents. It consists of 36 microneedles (250 μm in height) over an area of 5 × 5 mm. The needles are connected to a pen-like vibrator, which causes them to penetrate the skin with a frequency of 3000 times per minute. The diameter of each needle is only 80 nm, which is almost noninvasive. Utilizing this method, drug penetration can be increased by up to 10 or 20 times. PR can reduce the infraorbital hyperpigmentation and combination with nano-microneedle is superior. Nano-microneedle-assisted PR is a safe and reliable treatment for infraorbital dark circles. (RCT)

    Vitiligo

    • Dermapen microneedle plus topical tacrolimus outperformed either alone (RCT)

    Safety

    • Do microneedles penetrates cells and nuclei and damage organelles and DNA?
    • Wounding via dermarolling microneedling upregulated IGF-1 and resulted in lower levels of basal keratinocytes proliferating with unrepaired UV-B induced DNA damage (ref)
    • Microneedling is a minimally invasive medical facial that will only cause redness and a bit of inflammation. There is nothing involved in Microneedling that can increase your chances of getting cancer. Be sure to ask your doctor if Microneedling is the right treatment for you to get your desired results! https://skingenity.com (Dmitry Schwarzburg MD expert opinion)
    • Motorised forms may provide a more controlled wound than dermarollers
    • Always sterilise needles or use single use ones and don't overuse so they become blunt
    • Don't use it with topical therapies that should not be reaching high concentrations in the skin or body e.g. parabens containing topicals that are harmless when used topically but may be more estrogenic when microneedled into the skin (ref)
    • Sterilise or cleanse skin before to remove/kill microbiome
    • Contraindications, such as a breakout of herpes (cold sores), rosacea, acne, skin cancer, or thin skin from steroid use – and end up with infection and scarring

    Evidence-review Fractional Radiofrequency 

    PubMed RCT high accuracy literature search results:

     

    Acne 

    • 70% reduction at 2 months after 2 visits. 1.15 MHz radiofrequency energy setting (40- 49 mJ/pin); spot size, 20.5 mm × 20.5 mm; and a mode depth of 2-3. Treatment endpoints were mild edema and tolerable pain. For both treatment modalities, slight overlapping of 2-3 passes was performed. Postoperatively, patients applied a facial cooling mask with 5% boric acid lotion for 15-20 minutes immediately after completion of the procedure. FR device (GP699D, Shenzheng GSD Technology Co., Ltd.). Topical anesthesia was applied as follows: the face was cleansed with a mild soap and 75% alcohol, and a topical eutectic mixture of 2.5% lidocaine and 2.5% prilocaine (Beijing Unisplendour Pharmaceutical Co., Ltd.) was applied to the entire facial surface with plastic film occlusion for 60 minutes prior to treatment. The epidermis was disinfected with 5% chlorhexidine after removing the surface anesthetic. (RCT)

    Evidence-review LED light 

    Units

    • 1 mW/cm^2 = 10 W/m^2 
    • 1 mJ/cm^2 = 1 mW/cm^2 applied for 1 second
    • Multiply mW/cm^2 by s/1000 or W/m^2 by s/10000 to get J/cm^2
    • 1 J/cm^2  = total dose delivered in a session = 1000 mJ/cm^2
    • J/cm^2 = mw/cm^2 *s/1000
    • s = (J/cm^2 * 1000)/(mw/cm^2) 

     

    Safety

    • LED Red light of 630-700 nm is safe up to 480 J/cm^2, but with darker skin tones or those on photosensitising medication being more photosensitive and hence the safe upper limit may be lower (RCT)
    • LED can enhance the growth of existing cancers, cancers within the LEDs pathway should be excluded before use (mouse study 2021)

     

    Celluma evidence

    • 100+ testimonials from patients, doctors and athletes 

     

    Celluma specifications

    • Red light at 640 nm, blue light at 464 nm, infra red light at 880 nm
    • Acne mode powered: 0.3-2.5 mw/cm^2 (3-25 W/m^2) at up to one inch, but many regions only provide 3 W/m^2
    • Wrinkles/red light mode powered: 1 - 3.5 mw/cm^2 (10-35 W/m^2) at up to one inch, powered, but many regions provide 15 W/m^2+
    • Aches and pains mode powered or not: 5 - 15 mw/cm^2 (50-150 W/m^2) at up to one inch when over red LEDs, NIR LEDs peak around 4-7 mw/cm^2 (40 - 70 W/m^2), whilst blue LEDs under 0.5 mw/cm^2 (5 W/m^2)

     

    Celluma FDA/CE clearances

    • Humans and pets
    • Arthritis
    • Full Face Wrinkles
    • Periorbital Wrinkles
    • Muscle Spasm
    • Muscle & Joint Pain
    • Muscle Tissue Tension
    • Muscle & Joint Stiffness
    • Diminished Local Circulation
    • Inflammatory Acne Vulgaris
    • Androgenetic Alopecia (Hair loss)
    • Wound healing acceleration after laser ablative resurfacing of facial skin (CE only)

     

    Flexbeam evidence

    • Testimonials only

     

    Flexbeam specifications

    • Red LED 625-635 nm, NIR LED from 810-850 nm, 10 x 4 cm surface area per head, 3 heads = 30 x 12 cm 
    • Mode 1 = pulsed red 60 mw/cm^2 (600 W/m^2), pulsed NIR 35 mW/cm^2 (350 W/m^2) (35% power 40 hz), 0-2.5 cm depth
    • Mode 2 = pulsed red 48 mw/cm^2 (480 W/m^2) (80% duty), pulsed NIR 70 mW/cm^2 (700 W/m^2) (70% power, 9Hz), 2.5-4 cm depth
    • Mode 3 = pulsed red 1.2 mw/cm^2 (12 W/m^2), continuous wave NIR 100 mw/cm^2 (1000 W/m^2) (100% power), 4-10 cm depth 
    • 66 J/cm^2 NIR omnilux equivalent = 66000/35 = 1885 seconds = 30 mins mode 1
    • 126 J/cm^2 red omnilux equivalent = 126000/60 = 2100 seconds = 35 mins mode 1  

     

    Omnilux evidence

    • Multiple RCTs for certain models

     

    Omnilux specifications

    • Omnilux Revive 2: 105 mw/cm^2 (1050 W/m^2) at 1 - 10 cm distance, 633 nm +/- 6 nm, bandwidth 20 nm +/- 3 nm, LED active area size 15 x 35 cm 
    • Omnilux Plus: 830 +/- 5 nm NIR, 55 mw/cm^2 (550 w/m^2)  15 cm x 35 cm 

     

    PubMed RCT high accuracy literature search results:

     

    Acne

    • 470 nm 900 W/m^2 and 640 nm 800 W/m^2 light once weekly, using Soli-Tone 2500 lumifacial for 15 minutes, for 4 weeks, total of 4 sessions, at 4.5 cm (2 inches) away from the face provided 50% improvement in inflammatory acne only, reaching max improvement at 1 week and no further improvement afterwards, with results lasting at least 1 month after the last session (RCT)

     

    Post-op scaring

    • Omnilux LED system at 360 mW/cm^2 at 10 mm, treated at under 1 cm distance, at 633 +/- 6 nm, 3x per week for 3 weeks improved POSAS scores only if 160 J/cm^2 or 320 J/cm^2, but not 480 J/cm^2 (RCT)

     

    Skin rejuvenation

    • Omnilux revive and plus panels consecutively: 2x per week for 4 weeks 8 sessions total; 20 mins at dose of 126 J/cm2 red, 66 J/cm2 NIR; 35% reduction in wrinkles; 15% increase elasticity; mild borderline insignificant decrease in melanin; 75% saw excellent improvement at 3 months, 20% good, combined NIR and red saw highest patient satisfaction; increased collagen and elastin on Mason and VvG stains respectivel; increased il1b, il6, tnfa which clear damaged collagen and lay down new collagen; telaamgiectasia improvements (RCT)

     

     

Resources

Age reduction leaderboard

Rejuvenation Trials

Coaching

 

Channels

YouTube

Instagram

Facebook

LinkedIn

Blog

Twitter

WhatsApp

 

Our Brands

SleepHack.Me

WineSpan

Longevity.School

About Us

Our mission

Progress

Press

Oliver Zolman

 

Contact Us

oliver@20one.consulting

Support

Book a call

Send a message

Partnerships

Oliver Zolman MD for Schools

Oliver Zolman MD for Businesses

My Account

Members Portal

Copyright 2016-2023 20one Consulting Ltd.

Cambridge, UK

 

Legal

Products and Services do not provide medical advice. Do not make any changes to your health behaviours without consulting your licensed clinicians first. See the medical disclaimer within the terms and conditions.

 

Oliver Zolman does not give medical advice. The contents on this site and his related Products & Services are for health informational purposes only, not medical advice.

Terms & Conditions
Privacy Policy
    ×
    Terms & Conditions
    An executive summary of our terms and conditions are attached here:
    
    • These terms and conditions apply to the use of any of the Services or documents received from 20one Consulting and also to any websites in the www.oliverzolman.com domains; the “20one Content”. Where indicated, additional terms and conditions apply to specific Services or websites only.
    
    • Content may be accessible by the general public globally. Members of the general public may also find them of interest and may use them to inform discussions with practitioners or researchers and those who make decisions about the funding of care/ research. 
    
    • If you are an individual who chooses to access 20one Content, you should not rely on that information as professional medical advice or use it to replace any relationship with your doctor or other qualified healthcare or social care professional. For medical concerns, including decisions about medications and other treatments, individuals should always consult their doctor or, in serious cases, seek immediate assistance from emergency personnel. Individuals with any type of medical condition are specifically cautioned to seek professional medical advice before beginning any sort of health treatment. If you are a member of the public, 20one recommends that you should evaluate 20one Content together with your physician or another qualified healthcare or social care professional. 
    
    • In relation to the mention of any scientific evidence and the interpretation of it: It is in the nature of scientific debate that not all authors will agree on all matters. Further, published papers may be in error, or superseded by later research. It is the user's sole responsibility to assess all evidence and to reach a decision informed by it. 
    
    • Our 20one Content and staff do not provide medical advice. Our staff do not perform the practice of medicine through 20one.
    
    • The contents of 20one Content are scientific information only and is not intended to diagnose, treat, cure or prevent any disease, disorder, injury or to act as triage.
    
    • The 20one Content, such as text, graphics, images, information obtained from our licensors, and other material contained are for informational, educational and research purposes only
    
    • If staff whom 1) hold primary medical qualifications (medical degrees) – and who may or may not be registered and or licensed to practice medicine in any jurisdiction globally -  or 2) hold any statutory healthcare professional role as relevant to their jurisdiction; have contributed to the development of any 20one Content they are NOT acting in their capacity as any of the listed statutory healthcare professionals in the UK or statutory healthcare professionals as relevant to their international jurisdiction, only in their capacity as non-statutory scientific and health research consultants. 
    
    • You must not rely on the information supplied from 20one Content as an alternative to medical advice from your doctor or other professional healthcare provider.   
    
    • If you have any specific questions about any medical matter you should consult your doctor or other professional healthcare provider.
    
    • If you think you may be suffering from any medical condition you should seek immediate medical attention.  
    
    • You should never delay seeking medical advice, disregard medical advice, or discontinue medical treatment because of information included in our Services or websites
    
    • Reliance on any information from 20one Content is at your own risk. 20one is not responsible or liable for any advice, course of treatment, diagnosis, drug and device application or other information, services, or products that you obtain as a result of 20one Content we provide.
    
    • I am aware that I am strongly encouraged to discuss any 20one Content with my licensed doctor. We recommend you always consult an appropriate healthcare professional for advice on your specific circumstances and situation
    
    • You acknowledge and agree that 20one Content is not a substitute for actual medical diagnosis, treatment or consultation with a doctor, and that 20one Content does not constitute medical advice and/or recommendations for medical treatment regarding any aspect of your health, medicine intake, nutrition or lifestyle. 
    
    • 20one Consulting and Staff have made reasonable effort to ensure the accuracy of data or information used in 20one Consulting Deliverables. However, 20one Consulting Staff, Advisors and Associates cannot accept responsibility for any errors or omission, or for any consequences from application of the data or information provided through 20one Consulting Deliverables, and make no warranty, expressed or implied, with respect to the currency, completeness or accuracy of the data and information within 20one Consulting Deliverables.
    
    • No guarantee can be made whether developed Deliverables will meet your expectations for Deliverables recommendations or content, or that you will be able to implement these Deliverables as an organisation, a clinician or as an individual wanting a clinician to use such Deliverables.
     
    Terms & Conditions
     
    The Services provided by 20one Consulting Limited are available subject to the following terms and conditions.
    
    Context
     
    1.	The Services provided and associated resources such as websites or external documents are owned and operated by 20one Consulting Limited (“20one Consulting”) a private limited company registered in England and Wales, with company number 10299987. ("20one Consulting", "us", "our" or "we").
    
    2.	Our Services are only intended for English language fluent adults (age 18+), and not for children
    
    3.	These terms and conditions apply to the use of any of the Services, documents, websites in the www.20one.consulting or www.betterguidance.com, www.longevity.school or www.drzolman.com domains; the “20one websites”. Where indicated, additional terms and conditions apply to specific Services or websites only.
    
    4.	The Services and 20one websites provide information about 20one’s work, including its recommendations on the use of health technologies, guidelines on the research, management and treatment of particular conditions and its ongoing development of such recommendations and guidelines and other information.
    
    5.	Users must only use the Services and websites for purposes consistent with these Terms of Use including any conditions relating to specific Services or websites outlined below.
    
    6.	If you do not comply with these Terms of Use, we may block your access to the Services or websites.
    
    Background
    
    1.	The information provided in Services and on the 20one websites is there to inform those making decisions about the funding of care and research and to assist health and social care practitioners and researchers and others to improve the quality of care, treatment and research. 
    
    2.	The websites are also accessible by the general public globally. Members of the general public may also find them of interest and may use them to inform discussions with practitioners or researchers and those who make decisions about the funding of care or research. 
    
    3.	Information retrieved from the websites do not override the individual responsibility of healthcare and social care professionals involved in the delivery of care to make informed professional judgments appropriate to the circumstances of the individual, in consultation with the individual and/or their guardian or carer. 
    
    4.	Practitioners, commissioners, researchers and managers are reminded of their duties to avoid unlawful discrimination and to have regard to promoting equality of opportunity. No material on the websites should be interpreted in a way which would be inconsistent with compliance with those duties. 
    
    5.	If you are an individual who chooses to access the information on the websites, you should not rely on that information as professional medical advice or use it to replace any relationship with your doctor or other qualified healthcare or social care professional. For medical concerns, including decisions about medications and other treatments, individuals should always consult their doctor or, in serious cases, seek immediate assistance from emergency personnel. Individuals with any type of medical condition are specifically cautioned to seek professional medical advice before beginning any sort of health treatment. If you are a member of the public, 20one recommends that you should evaluate the information on the websites together with your physician or another qualified healthcare or social care professional. 
    
    6.	In relation to the mention of any scientific evidence and the interpretation of it: It is in the nature of scientific debate that not all authors will agree on all matters. Further, published papers may be in error, or superseded by later research. It is the user's sole responsibility to assess all evidence and to reach a decision informed by it. 
    
    Definitions 
    
    Except to the extent expressly provided otherwise, in these Terms and Conditions: 
    
    "Charges" means the following amounts: 
    
    a.	The amounts specified in the Statement of Work; 
     
    b.	such amounts as may be agreed in writing by the parties from time to time; and 
    
    c.	amounts calculated by multiplying the Client Manager’s standard time-based charging rates by the time spent by the Client Manager’s personnel performing the Services (rounded by the Client Manager to the nearest plus or minus 5 minutes);
    
    "Client Materials" means all works and materials supplied by or on behalf of the Client to the Client Manager for incorporation into the Deliverables or for some other use in connection with the Services; 
     
    "Client Manager" means the authorized representative of 20one Consulting
     
    "Contract" means a particular contract made under these Terms and Conditions between the Client Manager and the Client; 
     
    "Deliverables" means those specified in the Statement of Work that the Client Manager has agreed to deliver to the Client under these Terms and Conditions; 
     
    "Effective Date" means the date of receipt of the signed version of this document by the Client Manager 
     
    "Intellectual Property Rights" means all intellectual property rights wherever in the world, whether registrable or unregistrable, registered or unregistered, including any application or right of application for such rights (and these "intellectual property rights" include copyright and related rights, database rights, confidential information, trade secrets, know-how, business names, trade names, trade marks, service marks, passing off rights, unfair competition rights, patents, petty patents, utility models, semi-conductor topography rights and rights in designs); 
     
    "Services" means the consultancy services specified in the Statement of Work; 
     
    "Statement of Work" means a written statement of work agreed by or on behalf of each of the parties, this may be referred to other names in practice such as “Projects”, “Scope” and “Deliverables”; new Statement of Works will be created ongoingly during your relationship with 20one Consulting in which case this same contract shall apply to all;
     
    "Term" means the term of the Contract 
     
    "Terms and Conditions" means all the documentation containing the provisions of the Contract, namely the main body of these Terms and Conditions and the Statement of Work, including any amendments to that documentation from time to time; and 
     
    "Third Party Materials" means the works and/or materials comprised in the Deliverables (excluding the Client Materials), the Intellectual Property Rights in which are owned by a third party and which may be specified in the Statement of Work or which the parties agree in writing shall be incorporated into the Deliverables. 
    
    Availability of the websites
    
    1.	We will make reasonable endeavours to ensure that these websites are generally available but make no representation or guarantees as to such availability.
    
    2.	We reserve the right to withdraw access to all or any part of any of these websites for periods of time in order to modify any of the content, for scheduled or unscheduled maintenance and for other purposes, without notice to you.
    
    3.	As you will receive these websites via third party telecommunications networks, you acknowledge that 20one cannot guarantee that the availability of these websites will be uninterrupted or error free. Similarly, we cannot guarantee that the transmission of any information over such telecommunications networks will be secure nor that you will be able to access these websites at all times.
    
    4.	These websites are therefore provided to you on an “as is” and “as and when available” basis, and your use of these websites is at your own risk.
    
    Disclaimers in terms of use of our websites
    
    1.	We have processes in place to seek to ensure that the contents of these websites are accurate and that the links it publishes directing the user to third party websites function properly. However, we give no assurances regarding the currency, accuracy or applicability of any of the website's content.
    
    2.	Due to the nature of these websites we cannot guarantee the prompt editing or removal of any inappropriate or inaccurate information. If you find any information that is inaccurate or inappropriate then please contact us.
    
    3.	While we use virus checkers to check the content of these websites we are unable to guarantee that these websites will never be faulty, nor that it will work continuously, nor that it will be maintained in a fully operational condition nor virus and/or error free. However, we will use reasonable endeavours to correct serious faults reported by you as soon as we reasonably can.
    
    4.	You should always check any content before downloading. Any website content is downloaded by you at your own risk and on the basis that you will be solely responsible for any damage to your computer system or loss of data that result from the download of such content.
    
    5.	Without prejudice to any other limitations or exclusions of our liability in these Terms of Use we shall have no liability whatsoever in respect of any failure on our part to repair a fault in these websites or to provide continuous access to it.
    
    6.	Without prejudice to any other limitations or exclusions of our liability in these Terms of Use we shall have no liability whatsoever in respect of any inability on your part to obtain access to these websites whether through any denial of service, attack or otherwise.
    
    7.	You are responsible for the provision of and payment for all telecommunications services necessary to use these websites and all hardware, equipment and other services (including but not limited to computers, modems and any other communication equipment) necessary to use these websites.
    
    8.	We provide these websites to you without any conditions, warranties, or guarantees whether express or implied, including but not limited to any implied warranties or conditions as to the satisfactory quality or fitness for a particular purpose, which are expressly excluded to the extent permitted by law.
    
    Disclaimer & Acknowledgements in respect of the use of 20one’s Services, Documents & Websites
    
    General
    
    1.	The use of 20one’s Services, Documents & Websites is subject to any disclaimer included within the guidance and the following disclaimer which applies to any recipient of 20one’s Services, Documents & Websites whether they be a clinical professional, researcher or member of the public.
     
    2.	This guidance represents the view of 20one, which was arrived at after careful consideration of the evidence available. Healthcare professionals are expected to take it fully into account when exercising their clinical judgement. However, the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
    
    3.	Implementation of guidance is the responsibility of local commissioners and/or providers. Commissioners and providers are reminded that it is their responsibility to implement the guidance, in their local context, in light of their duties to avoid unlawful discrimination and to have regard to promoting equality of opportunity. Nothing in this guidance should be interpreted in a way which would be inconsistent with compliance with those duties.
    
    Nature of information
    
    1.	Our Services and websites do not provide medical advice.
     
    2.	The contents of our Services are scientific information only and is not intended to diagnose, treat, cure or prevent any disease, disorder, injury or to act as triage.
    
    3.	The contents of our Services and websites, such as text, graphics, images, information obtained from our licensors, and other material contained are for informational, educational and research purposes only
    
    4.	Our staff cannot provide medical advice, and may not be registered, licensed or insured to practice medicine in any certain jurisdiction. 
    
    5.	If staff whom hold primary medical qualifications (medical degrees) or other statutory healthcare professionals have contributed to the development of any work they are NOT acting in their capacity as any of the listed statutory healthcare professionals in the UK or as relevant to their international jurisdiction, only in their capacity as non-statutory scientific researchers. 
    
    6.	You must not rely on the information supplied from our Services or websites as an alternative to medical advice from your doctor or other professional healthcare provider.   
    
    7.	If you have any specific questions about any medical matter you should consult your doctor or other professional healthcare provider.
    
    8.	If you think you may be suffering from any medical condition you should seek immediate medical attention.  
    
    9.	You should never delay seeking medical advice, disregard medical advice, or discontinue medical treatment because of information included in our Services or websites
    
    10.	Reliance on any information from our Services or websites is at your own risk. 20one is not responsible or liable for any advice, course of treatment, diagnosis, drug and device application or other information, services, or products that you obtain as a result of Services or websites we provide.
    
    11.	I am aware that I am strongly encouraged to discuss any documents generated by the Services or websites with my licensed doctor. We recommend that you always consult an appropriate healthcare professional for advice on your specific circumstances and situation
    
    12.	You acknowledge and agree that the Services are not a substitute for actual medical diagnosis, treatment or consultation with a doctor, and that any of 20one’s information does not constitute medical advice and/or recommendations for medical treatment regarding any aspect of your health, medicine intake, nutrition or lifestyle. 
    
    3rd parties
     
    1.	Mention of specific companies, organisations or authorities within any of 20one Consulting’s products and services does not imply endorsement by 20one Consulting’s staff, advisors or associates, nor does mention of specific companies, organisations or authorities imply that they endorse any of the 20one Consulting products and services, or 20one Consulting’s staff, advisors or associates. 
    
    Information provided
    
    1.	20one Consulting and Staff have made reasonable effort to ensure the accuracy of data or information used in 20one Consulting Deliverables. However, 20one Consulting Staff, Advisors and Associates cannot accept responsibility for any errors or omission, or for any consequences from application of the data or information provided through 20one Consulting Deliverables, and make no warranty, expressed or implied, with respect to the currency, completeness or accuracy of the data and information within 20one Consulting Deliverables.
    
    2.	No guarantee can be made whether developed Deliverables will meet your expectations for Deliverables recommendations or content, or that you will be able to implement these Deliverables as an organisation, a clinician or as an individual wanting a clinician to use such Deliverables.
    
    Data security
    
    1.	Whilst 20one Consulting has gone to reasonable efforts to secure all client data through utilising security protocols, 20one Consulting holds no responsibility for the undesired breach, damage or loss of any such client data.   
    
    Personal injury 
    
    1.	20one Consulting holds no responsibility for any injury, damage or undesired alteration to the client’s body acquired during use of our service.
    
    Links
    
    1.	The Services and websites contain links to websites which are not under our control. These links are provided for your convenience only. We are not responsible for the availability or content of such other websites, nor for any products or services available from them. Any such link should not be seen as an endorsement by us of such websites, or any of the products or services contained on them. Links are made to or from the website at your own risk.
    
    2.	You should be aware that your use of such other websites may be subject to additional terms and conditions imposed by the owners of those websites. Your dealings with such third parties are between you and the third party, and we accept no liability as a result of you accessing such websites or entering into contractual arrangements with the operator in question.
    
    3.	Users may insert a simple link to the 20one websites from their own website provided that: 
    
    a.	the website on which the link appears contains no unlawful, obscene, or offensive content and does not contain any links to such content;
    
    b.	the website on which the link appears is not likely to cause anxiety, loss, harm or personal injury to its readers; and
    
    c.	the link in no way has a negative impact on the reputation of 20one.
    
    4.	We reserve the right to terminate any links to the website at any time without notice and at our sole and absolute discretion.
    
    Limitations and exclusions of liability 
    
    1.	Nothing in these Terms and Conditions will: 
     
    a.	limit or exclude any liability for death or personal injury resulting from negligence; 
     
    b.	limit or exclude any liability for fraud or fraudulent misrepresentation; 
     
    c.	limit any liabilities in any way that is not permitted under applicable law; or 
     
    d.	exclude any liabilities that may not be excluded under applicable law. 
     
    2.	The limitations and exclusions of liability set out in this document:
      
    a.	govern all liabilities arising under these Terms and Conditions or relating to the subject matter of these Terms and Conditions, including liabilities arising in contract, in tort (including negligence) and for breach of statutory duty, except to the extent expressly provided otherwise in these Terms and Conditions. 
     
    3.	Neither party shall be liable to the other party in respect of any loss of profits or anticipated savings. 
     
    4.	Neither party shall be liable to the other party in respect of any loss of revenue or income. 
     
    5.	Neither party shall be liable to the other party in respect of any loss of use or production. 
     
    6.	Neither party shall be liable to the other party in respect of any loss of business, contracts or opportunities. 
     
    7.	Neither party shall be liable to the other party in respect of any loss or corruption of any data, database or software. 
     
    8.	Neither party shall be liable to the other party in respect of any special, indirect or consequential loss or damage. 
    
    Jurisdiction
    
    1.	These Terms and Conditions shall be governed by and construed in accordance with English law. 
     
    2.	The courts of London or Cambridge, England shall have exclusive jurisdiction to adjudicate any dispute arising under or in connection with the Contract. 
    
    Amending these terms of use in respect to our websites only
    
    1.	From time to time 20one may at its sole discretion amend these Terms of Use relevant to our websites only. Your continuing use of these websites constitutes your acceptance of and agreement to any changed terms and conditions. 20one will post details of any such changes on the websites in a timely manner.
    
    Amending these terms of use in respect of consultancy Services
    
    1.	The Contract may not be varied except by a written document signed by or on behalf of each of the parties
    
    General (Breaches, Unenforceability, Contractual Rights Deals, Superseding)
    
    1.	No breach of any provision of the Contract shall be waived except with the express written consent of the party not in breach. 
     
    2.	If any provision of the Contract is determined by any court or other competent authority to be unlawful and/or unenforceable, the other provisions of the Contract will continue in effect. If any unlawful and/or unenforceable provision would be lawful or enforceable if part of it were deleted, that part will be deemed to be deleted, and the rest of the provision will continue in effect (unless that would contradict the clear intention of the parties, in which case the entirety of the relevant provision will be deemed to be deleted).  
     
    3.	The Contract is made for the benefit of the parties, and is not intended to benefit any third party or be enforceable by any third party. The rights of the parties to terminate, rescind, or agree any amendment, waiver, variation or settlement under or relating to the Contract are not subject to the consent of any third party.
    
    4.	Neither party may without the prior written consent of the other party assign, transfer, charge, license or otherwise deal in or dispose of any contractual rights or obligations under these Terms and Conditions. 
    
    5.	Subject to the relevant Clauses in this document, a Statement of Work, together with these Terms and Conditions, shall constitute the entire agreement between the parties in relation to the subject matter of that Statement of Work, and shall supersede all previous agreements, arrangements and understandings between the parties in respect of that subject matter.
    
    Term 
    
    4.	The Contract shall come into force upon the Effective Date. 
     
    5.	The Contract shall continue in force until the Client expresses in writing their desire for the termination of the contract 
    
    Services & Quality Assurance
    
    1.	The Client Manager shall provide the Services to the Client in accordance with these Terms and Conditions. 
     
    2.	The Client Manager shall provide the Services with in accordance with the standards of skill and care reasonably expected from a leading service provider in the Client Manager’s industry 
     
    Deliverables 
    
    1.	The Client Manager shall deliver the Deliverables to the Client. 
    
    2.	The Client Manager shall use reasonable endeavours to ensure that the Deliverables are delivered to the Client in accordance with the timetable set out in the Statement of Work. 
     
    3.	The Client Manager warrants to the Client that: 
     
    a.	the Deliverables will conform with the requirements of the Statement of Work; 
     
    b.	the Deliverables will be free from material defects; and 
     
    c.	the use of the Deliverables by the Client in accordance with these Terms and Conditions will not: 
     
    1.	breach the provisions of any law, statute or regulation; 
    2.	infringe any third party's Intellectual Property Rights; or 
    3.	give rise to any cause of action against the Client, 
    
    in each case in any jurisdiction and under any applicable law. 
    Charges 
    
    1.	The Client and the Client Manager shall agree the Charges prior to undertaking of any work 
    
    2.	The Client Manager may increase charges on a roughly annual basis to reflect changes in demand to the service or increases in quality or efficiency, in which case this will be discussed with the Client in advance
    
    3.	The Client shall pay the Charges to the Client Manager in accordance with these Terms and Conditions. 
    
    4.	The Charges rate shall be agreed separately to this document on a staff by staff basis and reviewed from time to time.
     
    5.	All amounts stated in or in relation to these Terms and Conditions are, unless the context requires otherwise, stated exclusive of any applicable value added taxes, which will be added to those amounts and payable by the Client to the Client Manager. 
    
    6.	Value added tax (VAT) shall be added to the fees and expenses as and to the extent required by law. 
    
    7.	In case VAT is not initially charged, the Client Manager has the right to charge such VAT later should it be determined by the relevant tax authorities that VAT should be charged. 
     
    Payments 
    
    1.	The Client Manager shall issue invoices for the Charges to the Client from time to time during the Term 
     
    2.	The Client must pay the Charges to the Client Manager within the period of 30 days following the receipt of an invoice issued
    
    3.	The Client must pay the Charges by debit card, credit card, direct debit, or bank transfer, using such payment details as are notified by the Client Manager to the Client from time to time.
     
    4.	If the Client does not pay any amount properly due to the Client Manager under these Terms and Conditions, the Client Manager may: 
    
    a.	charge the Client interest on the overdue amount at the rate of 8% per annum above the Bank of England base rate from time to time (which interest will accrue daily until the date of actual payment and be compounded at the end of each calendar month); or 
     
    b.	claim interest and statutory compensation from the Client pursuant to the Late Payment of Commercial Debts (Interest) Act 1998. 
    
    Warranties: Quality & Legality of Service
    
    1.	The Client Manager warrants to the Client that: 
    
    a.	the Client Manager has the legal right and authority to enter into the Contract and to perform its obligations under these Terms and Conditions;
    
    b.	the Client Manager will comply with all applicable legal and regulatory requirements applying to the exercise of the Client Manager’s rights and the fulfilment of the Client Manager‘s obligations under these Terms and Conditions; and
    
    c.	the Client Manager has or has access to all necessary know-how, expertise and experience to perform its obligations under these Terms and Conditions. 
     
    2.	The Client warrants to the Client Manager that it has the legal right and authority to enter into the Contract and to perform its obligations under these Terms and Conditions.
    
    3.	All of the parties' warranties and representations in respect of the subject matter of the Contract are expressly set out in these Terms and Conditions and the applicable Statement of Work. Subject to the relevant Clauses in this document, no other warranties or representations will be implied into the Contract and no other warranties or representations relating to the subject matter of the Contract will be implied into any other contract.
     
    Termination 
    
    1.	Either party may terminate the Contract by giving to the other party at least 30 days written notice of termination. 
     
    2.	Either party may terminate the Contract immediately by giving written notice of termination to the other party if the other party commits a material breach of these Terms and Conditions. 
     
    3.	Either party may terminate the Contract immediately by giving written notice of termination to the other party if: 
     
    a.	the other party: 
     
    1.	is dissolved; 
    2.	ceases to conduct all (or substantially all) of its business; 
    3.	is or becomes unable to pay its debts as they fall due; 
    4.	is or becomes insolvent or is declared insolvent; or 
    5.	convenes a meeting or makes or proposes to make any arrangement or composition with its creditors; 
     
    b.	an administrator, administrative receiver, liquidator, receiver, trustee, manager or similar is appointed over any of the assets of the other party; 
     
    c.	an order is made for the winding up of the other party, or the other party passes a resolution for its winding up (other than for the purpose of a solvent company reorganisation where the resulting entity will assume all the obligations of the other party under the Contract); or 
     
    d.	if that other party is an individual: 
    
    1.	that other party dies; 
    2.	as a result of illness or incapacity, that other party becomes incapable of managing his or her own affairs; or 
    3.	that other party is the subject of a bankruptcy petition or order. 
     
    Effects of termination 
    
    1.	Upon the termination of the Contract, all of the provisions of these Terms and Conditions shall cease to have effect, save that the following provisions of these Terms and Conditions shall survive and continue to have effect (in accordance with their express terms or otherwise indefinitely): [Clauses X]
     
    2.	The termination of the Contract shall not affect the accrued rights of either party. 
     
    Status of Client Manager 
    
    1.	The Client Manager is not an employee of the Client, but an independent contractor. 
    
    2.	The Client Manager is not acting in the role of a statutory healthcare professional, there is no doctor-patient relationship and no medical advice, including triage, diagnosis, preventive or reactive treatment can be provided. Do not make any changes to your health behaviours based on any of 20one’s Services, documents or websites without consulting your licensed healthcare professionals first.
     
    3.	The termination of the Contract will not constitute unfair dismissal; nor will the Client Manager be entitled to any compensation payments, redundancy payments or similar payments upon the termination of the Contract. 
    
    Subcontracting 
    
    1.	The Client Manager may subcontract any of its obligations under the Contract providing that the Consultant must give to the Client, promptly following the appointment of a subcontractor, a written notice specifying the subcontracted obligations and identifying the subcontractor in question. 
     
    2.	The Client Manager shall remain responsible to the Client for the performance of any subcontracted obligations.  
    
    Intellectual property rights
    
    1.	You acknowledge that all rights in copyright, patents, design rights, trade marks and other intellectual property rights (whether registered, capable of registration or otherwise) throughout the world, ("IP Rights") in the websites (including in all content) are owned by 20one and/or our licensors or other third parties, for the full duration of such rights.
    
    2.	Except for your use of the websites in accordance with these Terms of Use, you are granted no IP Rights in respect of the Services or websites or their content.
    
    3.	All trade marks, logos, titles, brand and product names ("the Trade Marks") which are featured on the website are owned by 20one, or our licensors.
    
    4.	You may only use or refer to the Trade Marks which are included in those extracts from the Services or website downloaded, copied or printed by you in accordance with these Terms of Use. Otherwise you must not offer or distribute any products or services under or by reference to the Trade Marks, or otherwise reproduce any of the Trade Marks without our express written consent
    
    5.	Reproduction, publication or distribution of the content from the website, including 20one copyright material, is subject to the following 'Notice of Rights'.
    
    Notice of rights
    
    Use of 20one content
    
    6.	Except for personal use, study or personal research, copyright content owned by 20one may not be used, reproduced, translated, distributed or transmitted in any form, in whole or in part, by any means, electronic, mechanical, photocopying, recording or other means, now known or hereafter invented, or used in any information or retrieval system, without the prior written agreement of 20one. Such an agreement may be subject to a licence and fee. 
    
    Third-party content included in 20one content
    
    7.	Some 20one content includes identifiable third-party content for which 20one will have sought permission for its inclusion. It is therefore for you to seek the necessary additional permission to re-use any content in the 20one content which is identifiable as being sourced from, or owned by, a third party. This may include, but is not limited to: text extracts, third-party review and comment, official publications, data, tables, illustrations and/or photography. This also includes content that 20one has acknowledged it has adapted. 20one makes no warranty in relation to any material identified as sourced from third parties in the 20one content.
    
    Third-party content hosted on the 20one website
    
    8.	The 20one website hosts identifiable third-party content under licensing agreements with the specific content providers. You may print copy or download the content from the website for educational and not-for-profit purposes only. It is therefore for you to seek permission directly from the content provider to re-use any hosted content which is identifiable as being owned by a third party.
    
    Products for Personal Use Only
    The products available on the Site, and any samples thereof we may provide to you, are for personal use only. You may not sell or resell any of the products or samples thereof that you purchase or otherwise receive from us. We reserve the right, with or without notice, to cancel or reduce the quantity of any order to be filled or products to be provided to you that we believe, in our sole discretion, may result in the violation of these Terms.
    Payment and Order Terms
    The Services enable you to order products from 20one Consulting. The amounts due and payable by you for any product that you purchase through the Services (including applicable taxes, shipping and handling) will be presented to you before you place your order. If you place an order for any products via the Services, you agree (a) that 20one Consulting may charge your credit card for verification, pre-authorization and payment purposes, and (b) to bear any additional charges that your bank or other financial service provider may levy on you as well as any taxes or fees that may apply to your order. Your order is not binding on 20one Consulting until accepted and confirmed by 20one Consulting.
    Subscriptions Automatically Renew Until you Cancel & How to Cancel Your Subscription
    All amounts are payable and charged: (i) for one-off purchases, at the time you place your order; and (ii) FOR SUBSCRIPTION-BASED PURCHASES, AT THE BEGINNING OF THE SUBSCRIPTION AND, BECAUSE EACH SUBSCRIPTION RENEWS AUTOMATICALLY UNTIL YOU CANCEL IT, AT THE TIME OF EACH RENEWAL UNTIL YOU CANCEL. You must cancel your subscription before it renews to avoid the billing of the fees for the next subscription period. YOU CAN CANCEL THE RENEWAL OF YOUR SUBSCRIPTION AT ANY TIME by contacting us by email at oliver@20one.consulting. You will not receive a refund for the fees you already paid for your current subscription period and you will continue to receive products ordered until the end of your current subscription period.
    When ordering, it is your responsibility to ensure that all information submitted to 20one Consulting is accurate. You may not be able to submit corrections after you place an order, and, if accepted, any corrections submitted after you place an order may significantly delay shipping of your order.
    Unless expressly specified payments made to us are non refundable.
    We reserve the right to limit the order quantity on any product, to extend the delivery timeline for any reason after the order has been placed and accepted, and/or refuse to ship product to you for any reason. If you have any concerns or objections regarding charges, you agree to raise them with us first and you agree not to cancel or reject any credit card charges unless you have made a reasonable attempt at resolving the matter directly with 20one Consulting.
    20one Consulting reserves the right to not process or to cancel your order in certain circumstances, for example, if your credit card is declined, if we suspect the request or order is fraudulent, or in other circumstances 20one Consulting deems appropriate in its sole discretion. 20one Consulting also reserves the right, in its sole discretion, to take steps to verify your identity in connection with your order. 20one Consulting will either not charge you or refund the charges for orders that we do not process or cancel.
    Risk of Loss, Return Policies, and FAQ
    Title to products passes from 20one Consulting to you upon shipment from 20one Consulting’s facility. For information on order processing and shipping, please see our Shipping FAQ. Please be aware that our shipping times are only estimates and are subject to change.
    If you desire to return any product you ordered through the Services, please refer to our Return Policy FAQ for how you may return the product.
    
    General Prohibitions and 20one Consulting’s Enforcement Rights
    You agree not to do any of the following:
    • Use the Services in any way, or upload, publish, submit or transmit any Content that: (i) infringes, misappropriates or violates a third party’s patent, copyright, trademark, trade secret, moral rights or other intellectual property rights, or rights of publicity or privacy; (ii) violates, or encourages any conduct that would violate, any applicable law or regulation or would give rise to civil liability; (iii) is fraudulent, false, misleading or deceptive; (iv) is defamatory, obscene, pornographic, vulgar or offensive; (v) promotes discrimination, bigotry, racism, hatred, harassment or harm against any individual or group; (vi) is violent or threatening or promotes violence or actions that are threatening to any person or entity; or (vii) promotes illegal or harmful activities or substances.
    • Use, display, mirror or frame the Services, or any individual element within the Services, 20one Consulting’s name, any 20one Consulting trademark, logo or other proprietary information, or the layout and design of any page or form contained on a page, without 20one Consulting’s express written consent;
    • Access, tamper with, or use non-public areas of the Services, Client’s computer systems, or the technical delivery systems of Client’s providers;
    • Attempt to probe, scan, or test the vulnerability of any 20one Consulting system or network or breach any security or authentication measures;
    • Avoid, bypass, remove, deactivate, impair, descramble or otherwise circumvent any technological measure implemented by 20one Consulting or any of 20one Consulting’s providers or any other third party (including another user) to protect the Services or Content;
    • Attempt to access or search the Services or Content or download Content from the Services through the use of any engine, software, tool, agent, device or mechanism (including spiders, robots, crawlers, data mining tools or the like) other than the software and/or search agents provided by 20one Consulting or other generally available third party web browsers;
    • Use any meta tags or other hidden text or metadata utilizing a 20one Consulting trademark, logo, URL or product name without 20one Consulting’s express written consent;
    • Use the Services or Content for any commercial purpose or for the benefit of any third party or in any manner not permitted by these Terms;
    • Attempt to decipher, decompile, disassemble or reverse engineer any of the software used to provide the Services or Content;
    • Interfere with, or attempt to interfere with, the access of any user, host or network, including, without limitation, sending a virus, overloading, flooding, spamming, or mail-bombing the Services;
    • Collect or store any personally identifiable information from the Services from other users of the Services without their express permission;
    • Impersonate or misrepresent your affiliation with any person or entity;
    • Violate any applicable law or regulation; or
    • Encourage or enable any other individual to do any of the foregoing.
    Although we’re not obligated to monitor access to or use of the Services or Content or to review or edit any Content, we have the right to do so for the purpose of operating the Services, to ensure compliance with these Terms, or to comply with applicable law or other legal requirements. We reserve the right, but are not obligated, to remove or disable access to any Content, at any time and without notice, including, but not limited to, if we, at our sole discretion, consider any Content to be objectionable or in violation of these Terms. We have the right to investigate violations of these Terms or conduct that affects the Services. We may also consult and cooperate with law enforcement authorities to prosecute users who violate the law.
    Links to Third Party Websites or Resources
    The Services may contain links to third-party websites or resources. We provide these links only as a convenience and are not responsible for the content, products or services on or available from those websites or resources or links displayed on such sites. You acknowledge sole responsibility for, and assume all risk arising from, your use of any third-party websites or resources.
    
    20one Consulting Products
    20one Consulting EXPRESSLY DISCLAIMS ALL LIABILITY FOR CLAIMS THAT ARE DUE TO NORMAL WEAR, PRODUCT MISUSE, ABUSE, PRODUCT MODIFICATION, IMPROPER PRODUCT SELECTION AND NON-COMPLIANCE WITH ANY PRINTED DIRECTIONS.
    TO THE EXTENT NOT PROHIBITED BY LAW, IN NO EVENT WILL 20ONE CONSULTING BE LIABLE FOR ANY SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL OR PUNITIVE DAMAGES, HOWEVER CAUSED AND REGARDLESS OF THE THEORY OF LIABILITY, ARISING OUT OF OR RELATED TO 20ONE CONSULTING’S PRODUCTS, EVEN IF 20ONE CONSULTING HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. IN NO EVENT WILL 20ONE CONSULTING’S LIABILITY EXCEED THE AMOUNT PAID BY YOU FOR THE PRODUCT UPON WHICH A CLAIM IS BASED. SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, SO THE ABOVE LIMITATION MAY NOT APPLY TO YOU.
    
    
    
    
    ×
    Privacy Policy
    Privacy Policy
    
    Template Privacy Notice For Our Patients/service users
    
    How we use and share your information to help you
    
    We need to keep a record of the care you receive to ensure that:
    
    •	  Professionals involved in your care have accurate and up-to-date information
    •	  We have all the information necessary for assessing your needs and providing   
      excellent care
    •	  Your concerns can be properly investigated if you raise a complaint
    •	  Accurate information about you is available if you:
    
    a)	 Move to another area
    b)	   Need to use another service
    c)	   See a different healthcare professional.
    
    Your record
    
    We have a duty to:
    
    •	  Maintain full and accurate records of the care we provide to you
    •	  Ensure that your records are confidential, secure and accurate
    •	  Provide a copy at your request that is an accessible format (e.g. in large type if you are partially sighted). Your record may include some or all of the following:
    
    a)	  Your name, address and date of birth
    b)	  Contacts we have had with you, such as appointments
    c)	  Notes and reports on your health
    d)	  Details of treatment and care, images and test results
    e)	  Information on medicines, side effects and allergies
    f)	  Relevant information from people who care for you and know you well, 
             such as health professionals and relatives.
    g)	  The staff who see you may also add notes on their professional 
           opinion.
    
    If you wish us to, and it is practical, we will discuss and agree with you what we are going to enter on your record and show you what we have recorded.
    
    
    Identifying you as an individual
    
    We have many patients/service users with similar names so it vitally important for all patients/service users to be properly identified as individuals.  In order to be absolutely sure that you have been correctly identified we may ask you for a number of pieces of information. Suitable items include:
    
    •	Full name
    •	Date of birth
    •	NHS number
    •	National Insurance number
    •	Passport as photo ID
    •	Driving licence as photo ID
    •	Permanent (home, not a temporary) address
    
    How you can help us to keep your health record accurate
    
    •	Let us know when you change address, telephone number or name
    •	Tell us if any information in your record is incorrect
    •	Give your consent so that we can share information about you with other health professionals to make sure you receive the right healthcare
    •	Tell us if you change your mind about how we share the information in your record.
    
    How 20One Clinic Ltd uses your contact details
    
    We take your privacy seriously so please let us know how you want us to contact you.
    
    •	  Telephone
    If you provide a mobile phone number: we may ring, leave a message or text you, so tell us if you do not want us to do so.
    If you provide a landline: we may leave a message, so tell us if you do not want us to do so.
    
    •	  Email
    If you provide us with your email address: we may use it send confidential health information, unless you have told us not to do so.
    Please read the following before providing us with your email address.
    
    a)	Emails can be quick and convenient and will allow you to keep a record 
          (unlike a phone call). However, although our own systems are secure, it 
          may be possible to intercept your email when it is being sent over the 
          internet.
    b)	Be aware also that if you share your computer others may read your 
          emails.
    c)	You could use email to contact staff in relation to a query or to ask 
          about an appointment.
    
    d)	Do not give more personal information than we need to process your 
          request.
    e)	Do not ask us to send you medical details that you would not want seen 
          by other people.
    
    If you have an urgent question or feel unwell after going home after treatment contact an emergency service e.g. 111 NHS emergency service or 999 for life threatening conditions by telephone, do NOT email.
    
    How your records are kept
    
    Our guiding principle is that we hold your records in strict confidence.
    
    20One Clinic Ltd is registered under the Data Protection Act 2018. It abides by the law and observes good practice in maintaining confidentiality and appropriate information security.
    
    We will fulfil its obligations under this Act to the fullest extent, including ensuring that the following eight principles governing the processing of personal data are observed.
    
    
    i.	personal data shall be processed fairly and lawfully;
    ii.	personal data shall be obtained only for specified and lawful purposes, and shall not be processed in any manner incompatible with those purposes;
    iii.	personal data shall be adequate, relevant and not excessive in relation to the purposes for which it is processed;
    iv.	personal data shall be accurate and, where necessary, kept up to date;
    v.	personal data shall be kept for no longer than is necessary for the purposes for which it is processed;
    vi.	personal data shall be processed in accordance with the rights of data subjects under the Act;
    vii.	personal data shall be subject to appropriate technical and organisational measures to protect against unauthorised or unlawful processing and accidental loss, destruction or damage;
    viii.	personal data shall not be transferred to a country or territory outside the European Economic Area unless that country or territory ensures an adequate level of data protection
    
    20One Clinic Ltd is also registered with the Care Quality Commission.   This means that we are subject to ongoing inspection and regulation by the CQC.  This includes checks by the CQC that we are observing all necessary and statutory guidelines for use of your data in line with Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 (Part 3).
    
    Information about you and the services you receive may be held in a number of formats and will be kept for the specific retention periods outlined by the relevant professional bodies.  We use secure electronic systems to store user records, images and details of prescriptions. Patient data held on paper or disk will be processed in accordance with the Data Protection Act and destroyed using secure documented procedures after the time periods set out by the Department of Health.
    How your records are used
    
    We use your records to:
    
    •	  Ensure that any treatment or advisory services we provide to you are based
      on accurate information.
    •	  Send a letter about your care to your GP or other health professional at the end of your treatment, unless you tell us not to do so.
    •	  Work effectively with other services providing you with treatment or advice.
    •	  Monitor the quality of our care and help us to understand the outcomes of  care.
    •	  Investigate any concerns or complaints you or your family have about your health care.
    •	  Provide information that is needed for financial transactions in relation to payment for treatment, such as billing. For private patients/service users this may include details shared with your insurance company. If you have any concerns about this, please contact your insurer.
    
    Anonymised data
    
    We may remove your name and other details that could identify you so that we can use the information in your record anonymously to:
    
    •	  Monitor and improve the quality of care received by patients/service users
    •	  Protect the health of the general public, for example we may share anonymous and aggregated patient information with organisations such as the National Institute for Clinical Excellence and the Cancer Registry for research or statistical purposes
    •	  Train and educate staff.
    
    Wherever possible, we anonymise your data or use a quasi- identifier such as a patient number or NHS number.
    
    Sharing your health record  
    
    20One Clinic Ltd has a designated Information Lead/Data Protection Officer who is responsible for protecting the confidentiality of patient information and making sure that information is shared where this is appropriate.
    
    To make sure you receive all the care and treatment you need, we may need to share the information in your health record with other staff and organisations. This could include:
    
    •	   Other healthcare professionals, such as doctors, pharmacists, and pathology 
     and radiology staff involved in the analysis and reporting of diagnostic tests
    •	   Other hospitals and private sector organisations involved in your care
    •	   Local authority departments
    •	 Voluntary organisations providing on-going support
    •	 Administrative support staff 
    Note that anyone who receives information from us also has a legal duty to keep it confidential.
    
    We may also share information that identifies you where: 
    
    •	You ask us to do so 
    •	We ask for specific permission and you agree to this 
    •	We are required to do this by law 
    •	We have special permission because we believe that the reasons for sharing are so important that they override our obligation of confidentiality (e.g. to prevent someone from being seriously harmed).We do not give the names and addresses of patients/service users to other organisations except under the circumstances described in this Privacy Notice. Unless you have signed an additional consent, we will not contact you after your visit for purposes other than: 
    
    a)	Follow up of care 
    b)	Collecting your views about your stay with us 
    c)	Settlement of any account that may be due, if appropriate
    d)	Complaints and concerns handling. 
    
    Sharing information with your family and friends 
    
    We will normally share information about the progress of your treatment with the person you name as your Emergency Contact, unless you have told us not to do so. Your emergency contact should be someone that you trust and feel close to. It does not have to be a blood relative; it can be a good friend. We ask patients/service users to name their emergency contact so that we know who you would like us to keep informed about the care we provide or the decisions we need to make. In identifying your emergency contact, you are giving us permission to keep her or him informed.  
    
    You can also name other people, with whom you would like us to share information about you. We make best efforts to ensure that information provided over the telephone is restricted to those you have named and we share on a need to know basis. Sometimes this means refusing to disclose information about you to someone who feels they should know about your treatment and progress. Please make your family and friends aware of this. 
    
    Special situations 
    
    Sometimes we have a legal duty to provide information about people; examples are reporting some infectious diseases, and when a court order instructs us to do so. Records may also be shared without the patient's consent in exceptional situations, such as to safeguard adults or children. 
    External Regulation 
    
    The Care Quality Commission is the independent regulator of health care and they also protect the interests of people whose rights are restricted under the Mental Health Act. They routinely inspect our premises to quality check information we hold and the services we provide in line with the Health & Social Care Acts. This is designed to ensure that patients/service users using services are protected and receive the care, treatment and support they need. These inspectors have the authority to access personal information without the permission of patients/service users. 
    
    Sharing your records outside the EU 
    
    If your permanent address is outside the EU, or your treatment is continuing outside the EU, we may send details of your treatment to individuals based outside the EU specifically to promote your ongoing care. This would normally be the doctor who referred you to us for treatment. If you wish, we can give you the documents so that you have physical control over this information. 
    
    In the usual course of our business, we may use third parties to process and store your data on our behalf. We normally store your data on secure servers in the European Economic Area (EEA). Such processing is subject to contractual restrictions with regard to confidentiality and security in addition to the obligations imposed by the Data Protection Act 2018. 
    Exceptionally we may make use our suppliers are based outside the EEA for processing and storing your data. We have strict controls over how and why your data can be accessed.  By submitting your personal data, you agree to this.
    Where necessary we may transfer personal information overseas for processing to support the long- term effectiveness of treatment and monitor patient outcomes. Personal information will be processed in this way where it is not possible to achieve this purpose with the use of anonymised or pseudonymised information only. 
    
    How can I stop my information from being shared? 
    
    20One Clinic Ltd acts to provide information principally for other health and social care professionals who have requested this since they require further detailed investigations on their patients/service users.  So naturally we will normally need to share this information with your doctor who has referred you to our service.
    
    If you do not want us to share your information with your GP, other healthcare providers or carers, please tell the team looking after you. But please note that not sharing your information may affect the care that can be provided for you.  
    
    You have the right to request that your confidential information is not used beyond your own care and treatment and to have your objections considered. Where your wishes cannot be followed you will be told the reasons including the legal basis. You may at any time withdraw any consent you have previously given to us to process information about you. 
    
    If you wish to exercise your right to opt-out, withdraw consent to use your information, or to speak to somebody to understand what impact this may have, please discuss your concerns with your professional, or email us typing ‘Opt Out Request’ in the subject line of the email. 
    
    Your legal rights 
    
    20One Clinic Ltd is the Data Controller of the data it holds about its patients/service users and staff. 
    
    You have the right to confidentiality under the Data Protection Act 2018 (DPA), the Human Rights Act 1998 and the Common Law Duty of Confidentiality. The Equality Act 2010 may also apply. 
    
    You have the right to know what information we hold about you, what we use it for and if the information is to be shared, who it will be shared with. 
    
    You have the right to apply for access to the information we hold about you. Other people can also apply to access your health records on your behalf. These include anyone authorised by you in writing (such as a solicitor), or any person appointed by a court to manage your affairs where you cannot manage them yourself. Access covers: 
    
    •	The right to obtain a copy of your record in permanent form; 
    •	The right to have the information provided to you in a way you can understand, and explained where necessary, for example where abbreviations have been used. You would not be entitled to see information that: 
    
    a)	Has been provided about you by someone else if they haven’t given permission for you to see it 
    b)	Identifies another person who has not given permission for you to see the information about them 
    c)	Relates to criminal offences 
    d)	Is being used to detect or prevent crime 
    e)	Could cause physical or mental harm to you or someone else. If you are currently receiving services from us and wish to view the record without obtaining a copy, discuss your request with the professional in charge of your care. 
    
    Obtaining a copy of your record 
    
    If you wish to apply for access to the information we hold about you: 
    
    •	You should send your request in writing to us.
    •	You should provide enough information to enable us to correctly identify your records, for example include your full name, address, date of birth, any unique identifier number/ NHS number (if known) 
    •	We will take every reasonable step respond to you within 40 days of receiving your request 
    •	You may be required to provide a form of ID before any information is released to you. Once you receive your records, if you believe any information is inaccurate or incorrect, please inform us. 
    
    Currency
    
    This Privacy Policy is effective immediately and will remain in effect until further notice.
    
    We reserve the right to update or change our Privacy Policy at any time and you should check this Privacy Policy periodically. Your continued use of the Service after we post any modifications to the Privacy Policy on this page will constitute your acknowledgment of the modifications and your consent to abide and be bound by the modified Privacy Policy
    
    
    Further Questions
    
    If you have any further questions about this Privacy Policy, or if anything is not clear, please let us know.  
    
    
    Further information about data protection issues is at:
    
    Information Commissioner’s Office (ICO) 
    The Information Commissioner’s Office Wycliffe HouseCheshire SK9 5AFHelpline: 08456 30 60 60 
    Website: www.ico.gov.uk 
    
     
    APPENDIX 2
    
    Privacy Notice For Our Staff
    
    This Privacy Notice explains how 20One Clinic Ltd handles and uses personal data we collect about staff. Where in this statement we refer to ‘we’ or ‘our’ or ‘us’ we are referring to 20One Clinic Ltd, and where we refer to ‘you’ or ‘your’ we are referring to our staff. 
    
    We are registered with the Information Commissioner's Office (ICO).  We are committed to protecting your personal information and to being transparent about what information we hold. 20One Clinic Ltd understands its obligations to you to help you understand how and why we process your personal data. This notice tells you about these uses and should be read in conjunction with the 20One Clinic Ltd data protection policy.
    
    Our data protection policy and procedures are governed by the Data Protection Act 2018 and the EU General Data Protection Regulation. 
    
    
    Why we hold your personal data
    
    We are required to hold your personal data for various legal and practical purposes, without which we would be unable to employ you.
    
    Holding your personal data enables us to meet various administrative and legal obligations (e.g. for tax purposes).
    
    We will also process your personal information in other circumstances, provided you have given your consent for us to do so.
    
    
    Lawful basis for processing personal data
    
    The lawful basis for processing the personal data of alumni and supporters as described in this document is to fulfil a contract with an individual.
    
    There is a contractual requirement for you to provide much of the information detailed. Without this we will be unable to fulfil our obligations which could result in the contract terminating.
    
    
    Personal data held by 20One Clinic Ltd 
    
    	
    The information we hold about you is primarily information you provided when applying for your job, supplemented by information generated in the course of your employment.
    
    In common with all data subjects:
    
    •	Your name
    •	Your contact details
    •	Unique personal identifiers and biographical information (e.g. date of birth)
    •	photographs of you;
    •	your attendance at 20One Clinic Ltd 
    •	personal data provided by you for a specific purpose or purposes (for example, disability, catering preferences or lifestyle status for event management);
    •	information related to the prevention and detection of crime and the safety of staff and service users including, but not limited to, CCTV recording;
    
    
    Also:
    •	financial information gathered for the purposes of your employment with us
    •	your visa requirements; copies of passports, visas, and other documents required to ensure compliance with Home Office requirements.
    •	Details of your education, qualifications and publications.
    
    Particular to staff:
    •	your application and curriculum vitae;
    •	details of your career;
    •	references.
    •	your contract of employment;
    •	performance reviews;
    •	disciplinary, grievance and capability procedures;
    •	accidents at work; and
    •	training provided.
    
    Sensitive personal data held by 20One Clinic Ltd 
    
    The information we hold is that which you provide to us (for example, you may give us information by filling in forms on our website, or by corresponding with us by post, telephone, and email or otherwise).
    
    Records may contain:
    •	your religious affiliation
    •	how your personal data is used by 20One Clinic Ltd Your 	data is used by us for a number of purposes including: Publications, invitations and other 	communications.
    •	e-news and flash emails.
    •	internal reporting and record keeping.
    •	administrative purposes (e.g. in order to process fees payments or to administer an 	event you have registered for or attended).
    •	Responding to data access requests you make.
    
    Also:
    •	Giving key card access to parts of the premises (if appropriate)
    •	issuing references at your request.
    •	Contacting you, your next of kin, or other relevant contact in case of an emergency.
    •	Inclusion in our directories.
    •	Marketing, including images, online, in print and on social media (with your consent)
    
    Communications to you may be sent by post, telephone or a work email address. Your personal mobile phone number will only be used if you have given consent.
    
    If you have concerns or queries about any of these purposes, or how we communicate with you, please contact us at the address given below. We will always respect a request by you to stop processing your personal data, and in addition your statutory rights are set out below.
    
    
    Sharing your data with others
    
    Within 20One Clinic Ltd, personal data, including sensitive personal data, may be shared between members of staff who legitimately need the information to carry out their normal duties to support your time with us. We endeavour to ensure that sensitive personal data is only shared with colleagues with your explicit consent. However, circumstances may arise where this data is shared with colleagues without gaining your consent. This will only occur if it is necessary to protect your vital interests or the vital interests of another person; or for certain other reasons where it is not possible or appropriate to gain your consent such as disclosures to the police for prevention or detection of crime, or to meet statutory obligations relating to equality monitoring.
    
    20One Clinic Ltd may disclose certain personal data to third parties. These external organisations, and the purpose for sharing the information, are set out below.
    
    Relevant data, including your bank details, will be shared with our payroll providers and may be shared with our accountants (for payment of expenses).
    
    Relevant data may be shared with your next of kin but only with your consent or in an emergency.
    
    Relevant data may be shared with Home Office, UK Visas and Immigration (UKVI) in order to fulfil any obligations as a visa sponsor.
    
    Data may be shared with reputable “data processors” for the purposes of sending communications (e.g. mailchimp).
    
    With your permission we may share information about you for publicity and marketing purposes online, in print and on social media.
    
    Otherwise, 20One Clinic Ltd does not share data with any third party, except as allowed for in other privacy notices or required by law. We do not sell your personal data to third parties under any circumstances, or permit third parties to sell on the data we have shared with them.
    Transfer of personal data to other countries
    Where data is shared within the UK, or the European Union (EU), the third party will be required to comply with and safeguard the data under the terms of the DPA and appropriate EU regulations.
    
    Your personal information will only be transferred to countries, outside of the EU, whose data protection laws have been assessed as adequate by the European Commission, or where adequate safeguards, such as the EU-US Privacy Shield, are in place.
    How long data is kept
    We will keep your personal data only as long as is necessary for the purpose(s) for which it was collected, and in accordance with our Data Protection Policy. Data will be securely destroyed when no longer required. Where you exercise your right to erasure, we will continue to maintain a core set of personal data (name, dates of working at 20One Clinic Ltd and date of birth) to ensure we do not contact you inadvertently in future, and to maintain your record for archive purposes. We may also need to retain some financial records about you for statutory purposes (e.g. accounting matters).
    Your rights
    
    You have the following rights
    
    To be informed	This Privacy Notice provides the information you are entitled to receive
    Access	Please contact us if you would like confirmation that your data is being processed and access to your personal data.
    
    There is no charge for us providing you with this data and it will usually be provided within a month of the request (unless the request is unfounded or excessive).
    Rectification	Please inform us of any data which you would like rectified and we will usually respond within a month of the request.
    
    We will pass on the changes to any third parties who need to change their records and let you know this has been done.
    Erasure	You may exercise your right to have your personal data erased in a number of circumstances (e.g. if the data is no longer necessary in relation to the purpose for which it was created or you withdraw your consent). Where possible we will comply with all such requests, though some details are part of the
    College’s permanent records (e.g. examination results, college photographs)
    which cannot reasonably be deleted.
    Restrict processing	You can tell us that we can keep your data but must stop processing it, including preventing future mailings and communications.
    
    If possible we will inform any third parties to whom your data has been disclosed of your requirement.
    Data portability	Your data is across manual records and a bespoke Access database. We will do our best to provide information in a portable format but it is unlikely that we
    can create systems to do so.
    to object	If we can, we will stop processing your data if you object to processing based on legitimate interests or the performance of a task in the public interest / exercise of official authority (including profiling).
    
    We will stop processing your data for direct marketing if you tell us to.
    
    We will stop processing your data if you object to processing for purposes of research and statistics.
    Not to be subject to automated decision-making
    including profiling	We do not use any automated decision-making.
    
    
    We reserve the right to judge what information we must continue to hold to be able
    to fulfil our contract with you.
    
    You have the right to lodge a complaint with the Information Commissioner’s Office at https://ico.org.uk/concerns.
    Further information
    
    The controller for your personal data and our Data Protection Officer is our CQC Registered Manager or nominee.  Please ask for details
    
    Our Data Protection Officer is responsible for monitoring compliance with relevant legislation in relation to the protection of personal data. Please contact us if you have any concerns or questions about the above information or you wish to ask us not to process your personal data for particular purposes or to erase your data. Where you have specific requests relating to how we manage your data, we will endeavour to resolve these, but please note that there may be circumstances where we cannot comply with specific requests.
    
    We will publish on our website any changes we make to this data protection statement and notify you by other communication channels where appropriate.
    
    -
    
    Confidential & Non-Disclosure Agreement for Services
    
    1. Definitions
     
    “Information” shall mean all material relating to personal health or the health sector disclosed by either Party and information which is disclosed to the receiving Party in connection with any client health data, health service, health decision, business discussion, conference or other dealings between the Parties, whether written visual or oral, which shall include but shall not be limited to previous health data, newly acquired health data in the course of business, all other health data, trade secrets, systems, concepts, designs, configurations, techniques, copyrighted matter patented or patentable inventions, plans, methods, drawings, data, documents or other paperwork, computer programs, narratives, but also includes business and marketing plans, dealings arrangements, objectives, locations and customer information. 
    
    “Third Party” shall mean any individual, firm, association or body corporate that is not a staff member of 20one Consulting and is not the Client themselves. 
    
    2. Undertaking 
     
    1.	The Parties acknowledge that in order to enable them to conduct a business relationship, each Party may be required to disseminate the other Party’s Information to various employees or partners. 
    
    2.	Each Party undertakes to cause any of its staff or third parties to whom such Information is transmitted to be bound to the same obligation of secrecy and confidentiality to which the Parties are bound under this Agreement.
    
    3.	In all cases in which information is to be shared from beyond the Parties, neither Party shall communicate the other Party’s information in any form to any other staff or partner without the other Party’s prior written consent unless either Party has agreed to the sharing of their data in a specific way previously.
    
    4.	In the case of seeking review by another staff member or partner or Third Party, information will be fully anonymised to be untraceable to the client by default to 20one Consulting’s best efforts; unless stated in writing by the client; or unless the receiving Third Party requires identification to provide such information and it is judged by the disclosing Party to be to the other Party’s benefit with no identified potential harms. 
     
    5.	Notwithstanding Clause 2.1, it is acknowledged that certain information may be required to be communicated to Third Parties, but neither Party shall communicate the other Party's information in any form to any Third Party without the other Party's prior written consent. 
    
    6.	Written consent is necessary for any information to be disclosed to any Third Party, which can only be disclosed pursuant to a non-disclosure agreement between the Party providing the information and the Third Party unless agreed upon in writing before.
    
    7.	That non-disclosure agreement shall conform to this Agreement, any variation being subject to the written consent of the other Party. 
    
    8.	The receiving Party agrees that information shall not be copied or reproduced by it or submitted to a Third Party without the express permission of the disclosing Party. 
    
    9.	The receiving Party shall use the information only for its own review and service purposes and shall not use the information to develop any service beyond those provided by 20one Consulting unless agreed by the disclosing Party.
    
    10.	Third Parties must not use received information for its own financial or other benefit, beyond what is needed to perform the Statement of Work
    
    a.	Exceptions should be agreed to be discussed between the Parties
     
    11.	Neither party shall use any relevant information for the purpose of making any investment, collaboration, funding or other business decision in relation to any of a Party’s business partners that are disclosed to the other Party. 
    
    a.	Business Partners include service provider partners of the Parties and organisations or persons who are recipient of investment by the Parties
    
    b.	If either party wishes to initiate an investment, collaboration or other business decision in relation to either Party’s business partners, this should be discussed between the Parties and terms agreed and signed in writing 
    
    12.	In addition, the Parties further agree that you shall not without the other Party’s prior written consent, meet with, solicit, contact or otherwise pursue any business relationship (whether as investor, funder, partner or other relationship) with any disclosed business partner of either Party. 
    
    13.	If the case where a Party is not clear what constitutes a business partner of either Party, they should confirm this with the corresponding Party
     
    3. Intellectual property rights 
     
    1.	The Parties agree that all rights to the information shall be and remain the property of the originating Party  
    
    2.	Nothing contained in this Agreement shall affect the respective rights of each Party.
    
    3.	This Agreement shall not operate as a direct or indirect assignment or license or public disclosure of any patent, copyright, registered design, trademark or any other proprietary right held by either Party.
    
    4. Survival of terms
     
    1.	The obligation of this Agreement shall terminate only with respect to a portion of a Party's information: 
    
    a.	If either Party can show that the information received from the other is or has become generally available to the public through no violation of the terms of this Agreement; 
    
    b.	If either Party at any time lawfully obtains such information in writing from a Third Party under circumstances permitting its disclosure, or 
    
    c.	If such information is disclosed with the prior written consent of the Party to whom such information belongs, provided that any disclosure complies in all respect with Clause 2 and the terms of such written consent. 
    
    regards to all information disclosed by either Party, the obligations of this Agreement with respect to either Party’s Confidential Information shall not terminate after the date this Agreement is executed by the Parties.
    
    2.	Upon termination either Party shall within ten (10) days of a written request received from the other Party return all the information provided by that Party as shall be specified in the written request. 
    
    5. Injunctive relief
    
    1.	The Parties agree that in the event of any violation or threatened violation of this Agreement, the injured Party shall be authorised and entitled to obtain from any court of competent jurisdiction injunctive relief, as well as an equitable accounting of all profits or benefits arising from such violation. 
     
    6. Governing law 
     
    1.	This Agreement shall be governed by and construed in accordance with English law and both Parties shall submit to the exclusive jurisdiction of the Courts of England and Wales, and shall be dealt with in the courts of London or Cambridge.
     
    7. Severability
     
    1.	If a court finds any provision of this Agreement invalid or unenforceable, the offending clause shall be amended to give effect to this Agreement, (so far as such clause may be amended), and the remainder of this Agreement shall be interpreted so as to give effect the intent of the parties 
     
    8. Relationships
     
    1.	Nothing contained in this Agreement shall be deemed to constitute either party apartner, joint venturer or employee of the other party for any purpose. 
     
    9. Integration
     
    1.	This Agreement expresses the complete understanding of the parties with respect to the subject matter and supersedes all prior proposals, agreements, representations, and understandings. This Agreement may not be amended except in a writing signed by both parties. 
    
    10. Waiver
     
    1.	The failure to exercise any right provided in this Agreement shall not be a waiver of prior or subsequent rights. 
    
    Email, internet and mobile communication (electronic communications)
    
    1.	20one Consulting provides requires Clients to communicate by electronic communications via end-to-end encrypted messaging applications, however clients may choose to use e-mail. Transmitting confidential health information by e-mail, however, has several risks, both general and specific, that should be considered before using e-mail. 
    
    a.	Risks: 
    
    i.	General e-mail risks are the following: e-mail can be immediately broadcast worldwide and be received by many intended and unintended recipients; recipients can forward e-mail messages to other recipients without the original sender(s) permission or knowledge; users can easily misaddress an e-mail; e-mail is easier to falsify than handwritten or signed documents; backup copies of e-mail may exist even after the sender or the recipient has deleted his/her copy. 
    
    ii.	Specific e-mail risks are the following; clients who send or receive e-mail from their place of employment risk having their employer read their e-mail. 
    
    iii.	The Client should understand that if for any reason they choose to disclose information regards sensitive medical history, this should not be done via email, and doing so it at their own risk due to the aforementioned general and specific risks; this include but are not limited to communications concerning diagnosis or treatment of AIDS/HIV infection; other sexually transmissible or communicable diseases, such as syphilis, gonorrhoea, herpes, and the like; behavioural health, mental health or developmental disability; or alcohol and drug abuse.
    
    b.	20one Consulting will use reasonable means to protect the security and confidentiality of e-mail or electronic communications. Because of the risks outlined above, we cannot, however, guarantee the security and confidentiality of e-mail or internet communication. 
    
    c.	20one Consulting endeavour to encourage the use of electronic communication means other than e-mail, such as end to end encrypted internet-based messaging apps, of which may not have the same specific or general risks of email-based communication
    
    d.	If the Client uses email or other electronic communications methods as a means to communicate sensitive information, the Client consents to the use of that electronic communications methods for confidential information after having been informed of the above risks. Consent to the use of electronic communications, including e-mail includes agreement with the following conditions: 
    
    i.	20one may forward electronically communicated messages to other 20one staff members as appropriate to provide the Services, 20one will not, however, forward messages to a 3rd party without the consent of the client as required by law. 
    
    ii.	20one will endeavour to read a message promptly but can provide no assurance that the recipient of a message will read the message promptly.
    
    iii.	It is the responsibility of the sender to determine whether the intended recipient received the message and when the recipient will respond. 
    
    iv.	20one Consulting cannot guarantee that electronic communications will be private. However, we will take reasonable steps to protect the confidentiality of the message but 20one Consulting is not liable for improper disclosure of confidential information not caused by its employee’s gross negligence or wanton misconduct.
    
    v.	If consent is given for the use of electronic communications, it is the responsibility of the Client to inform 20one Consulting of any types of information you do not want to be sent by each method of electronic communications. 
    
    vi.	It is the responsibility of the client to protect their password or other means of access to electronic communications services sent or received from 20one Consulting to protect confidentiality. 20one Consulting strongly recommends protecting your electronic communications service accounts with 2 factor authentication where possible and signing out immediately after completing your work. 20one Consulting is not liable for breaches of confidentiality caused by the client. Any further use of any particular electronic communications service initiated by the client that discusses sensitive information constitutes informed consent to the foregoing. 
    
    I understand that my consent to the use of electronic communications and e-mail may be withdrawn at any time by electronic communications or written communication to 20one Consulting. 
    
    I have read this section carefully and understand the risks and responsibilities associated with the use of electronic communications and particularly e-mail.
    
    By signing at the foot of this document I agree to assume all risks associated with the use of electronic communications and e-mail. 
    
    Use of your data 
    
    1. Confidentiality and your data 
     
    1.	Your identifiable data will not be accessible by anyone other than the minimal number of 20one Consulting staff and service providers as to provide Services
    
    2.	Your data will only be visible by 20one Consulting staff and service providers for the purposes of delivering Services.
    
    3.	Where possible your data will be fully anonymised prior to sharing with other 20one Consulting staff or service providers.  
     
    2. Data collected (including audio, video and photographic data)
    
    1.	We may collect the following Data, which includes personal Data, from you: Name, date of birth, health data including genomic, medical imaging, height, weight, ethnicity, bodily fluid test results
    
    2.	in each case, in accordance with this agreement. 
    
    3.	We will retain any Data you submit for as long as is needed to provide a Service to you or until requested for any or all your data to be removed or changed. 
    
    3. Data management
    
    1.	For purposes of the Data Protection Act 1998, 20one Consulting is the "data controller". 
    
    2.	We will retain any Data you submit for as long as is needed to provide a service to you or until requested for any or all of your data to be removed or changed. 
    
    3.	In the case where you request any of your data to be removed or changed, we will consult with the legal, regulatory or other requirements relevant to such data in order to determine the extent of actions we can provide. For example, we may be required to store certain health data for certain minimum periods of time to satisfy audit requirements by regulators, or tax requirements by governments.
     
    4.	Unless we are obliged or permitted by law to do so, and subject to any third-party disclosures specifically set out in this policy, your Data will not be disclosed to third parties. 
     
    5.	All personal Data is stored securely in accordance with the principles of the Data Protection Act 1998.
     
    6.	Any or all the above Data may be required by us from time to time in order to provide you with the best possible service and experience when using our services. Specifically, Data may be used by us for the following reasons: 
    
    a.	provision of the Services 
    
    b.	in each case, in accordance with this privacy policy. 
     
    4. Accessing your data
     
    1.	You have the right to ask for a copy of any of your personal Data held by 20one Consulting (where such Data is held) for a cost reasonable for the staff time and necessary hardware, software and services to deliver such data. 
     
    5. Data security
     
    1.	Data security is of great importance to 20one Consulting and to protect your Data we have put in place suitable physical, electronic and managerial procedures to safeguard and secure Data collected 
     
    2.	If password access is required for certain parts of the service, you are responsible for keeping this password confidential. 
     
    3.	We endeavour to do our best to protect your personal Data. However, transmission and or storage of information over the internet is not entirely secure and is done at your own risk. We cannot ensure the security of your Data transmitted or stored via our services. 
    
    4.	If chosen to opt out of any security recommendation, security software, or security hardware we advise to you of which makes 20one Consulting’s data practices not compliant with the Data Protection Act, 20one Consulting hold no liability for any breach, damage or loss of your data. 
    
    a.	20one Consulting will go to their best efforts to notify you when this is occurring and to inform you of potential alternative practises and risks with current practice. 
    
    b.	Written informed consent from the Client will be obtained, certifying that they opt out of Data Protection Act compliant security practice. This written informed consent will be stored. 20one Consulting have included this term to allow a more personalised experience if a client should want to use their own software and hardware in a manner not advised by 20one Consulting. 
    
    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More